Industry Connections
This content and the opinions expressed herein are those of the supporter or industry event provider and not those of the San Antonio Breast Cancer Symposium (SABCS®).
The San Antonio Breast Cancer Symposium (SABCS®) has no editorial oversight in the creation of content provided or supported by industry.
Provided Content
-
What Academic Breast Oncologists Are Discussing About ctDNA in Clinical Decision-Making
Circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing is rapidly becoming an essential tool in personalized surveillance strategies across early-stage and advanced breast cancer.
-
VISIT GENENTECH BOOTH #125 for the INAVO120 OS and PFS data
There’s a lot in store for you at the 2026 San Antonio Breast Cancer Symposium® (SABCS). Come by the booth to see the INAVO120 PFS and OS data for the Itovebi® (inavolisib) regimen. Our Genentech representatives are looking forward to sharing the details with you.
Supported Content